Nadeem Khan Selected Research

nicotinic acid benzyl ester

1/2011	Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy.
5/2010	Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadeem Khan Research Topics

Disease

30	Neoplasms (Cancer) 01/2018 - 07/2004
10	Hypoxia (Hypoxemia) 01/2018 - 01/2005
8	Glioma (Gliomas) 04/2015 - 03/2009
7	Stroke (Strokes) 07/2022 - 01/2014
5	Hyperoxia 07/2016 - 06/2005
4	Infections 01/2021 - 06/2013
4	Infarction (Infarctions) 01/2020 - 01/2008
3	Hyperalgesia 03/2022 - 11/2008
3	Fibrosarcoma 07/2016 - 07/2004
3	Wounds and Injuries (Trauma) 02/2016 - 01/2008
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2015 - 08/2004
2	Ischemic Stroke 07/2022 - 12/2017
2	Anemia 01/2022 - 06/2004
2	COVID-19 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 12/2006
2	Ischemia 01/2015 - 01/2008
2	Heart Failure 01/2014 - 01/2012
2	Hyperthermia 01/2014 - 02/2013
2	Burns 06/2013 - 01/2008
2	Pain (Aches) 05/2009 - 11/2008
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2022
1	Tobacco Use Disorder (Nicotine Dependence) 03/2022
1	Tremor (Tremors) 03/2022
1	Cardiotoxicity 01/2022
1	Iron Deficiencies 01/2022
1	Necrosis 01/2022
1	Postoperative Pain 07/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Pseudomonas Infections 01/2021
1	Atrial Fibrillation 12/2020
1	Takotsubo Cardiomyopathy 12/2020
1	Edema (Dropsy) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Liver Neoplasms (Liver Cancer) 11/2019
1	Thromboembolism 12/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2017
1	Thoracic Injuries (Chest Injury) 02/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Insulin Resistance 02/2016

Drug/Important Bio-Agent (IBA)

25	Oxygen (Dioxygen)IBA 12/2017 - 01/2005
7	carbogenIBA 07/2016 - 03/2009
5	lithium phthalocyanineIBA 07/2016 - 07/2004
4	AntioxidantsIBA 01/2022 - 01/2008
4	Gemcitabine FDA Link 09/2017 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
3	Pharmaceutical PreparationsIBA 01/2015 - 01/2011
3	efaproxiral (RSR-13)IBA 08/2007 - 07/2004
3	Hemoglobins (Hemoglobin)IBA 04/2005 - 06/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2022 - 01/2020
2	CytokinesIBA 01/2021 - 01/2020
2	Cytidine Triphosphate (CTP)IBA 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 02/2016 - 06/2013
2	Adenosine Triphosphate (ATP)IBA 02/2016 - 06/2013
2	Proteins (Proteins, Gene)FDA Link 02/2016 - 12/2006
2	MK-8776IBA 04/2015 - 12/2013
2	chinese inkIBA 01/2014 - 01/2005
2	ferric oxide (iron oxide)IBA 02/2013 - 02/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2011 - 01/2011
2	nicotinic acid benzyl esterIBA 01/2011 - 05/2010
2	Vasodilator Agents (Vasodilators)IBA 01/2011 - 05/2010
2	Streptozocin (Streptozotocin)FDA Link 05/2009 - 11/2008
2	platinum oxideIBA 06/2005 - 01/2005
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 03/2022
1	MecamylamineIBA 03/2022
1	Nicotine FDA Link 03/2022
1	AlloxanIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	CatalaseIBA 01/2022
1	ChlorophyllIBA 01/2022
1	EndonucleasesIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	IronIBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 07/2021
1	PPAR gammaIBA 01/2021
1	N-(3-oxododecanoyl)homoserine lactoneIBA 01/2021
1	trans-sodium crocetinate (crocetin)IBA 12/2020
1	Pyridinolcarbamate (P23)IBA 01/2020
1	InflammasomesIBA 01/2020
1	CarcinogensIBA 11/2019
1	acetamideIBA 11/2019
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2017
1	Mitochondrial Uncoupling ProteinsIBA 02/2016
1	Insulin (Novolin)FDA Link 02/2016

Therapy/Procedure

13	Therapeutics 01/2016 - 08/2004
12	Radiotherapy 01/2014 - 07/2004
8	Drug Therapy (Chemotherapy) 01/2018 - 01/2010
4	Thrombectomy 07/2022 - 01/2019
3	Punctures 01/2021 - 02/2016
2	Aftercare (After-Treatment) 01/2012 - 08/2007
1	Length of Stay 07/2022
1	Early Ambulation 07/2021
1	Ligation 01/2021
1	Cryosurgery 12/2020
1	Time-to-Treatment 01/2020
1	Craniotomy 03/2017